GRI Bio, Inc.
GRI
$1.80
-$0.20-10.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 43.19% | 34.41% | -36.50% | -58.29% | -28.53% |
| Total Depreciation and Amortization | -100.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -11.32% | -80.95% | 61.22% | 917.02% | 150.48% |
| Change in Net Operating Assets | 145.73% | -260.67% | -288.12% | 392.27% | -253.99% |
| Cash from Operations | 54.33% | -112.27% | -48.62% | -1.98% | -47.87% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -76.52% | -- | 236.56% | 57.59% | 19.78% |
| Repurchase of Common Stock | -- | 0.00% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 94.65% | -3,040.00% | -786.46% | -2.19% | -67.68% |
| Cash from Financing | -73.14% | 59,227.27% | 213.37% | 88.50% | 13.72% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -105.49% | 261.36% | 1,380.14% | 33.60% | -18.61% |